Facet browsing currently unavailable
Page 4 of 20620 results
Sort by: relevance publication year
Effect of Chemotherapy on Skeletal Health in Male Survivors from Testicular Cancer and Lymphoma JOURNAL ARTICLE published 1 November 2006 in Clinical Cancer Research |
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval JOURNAL ARTICLE published 1 December 2020 in Clinical Cancer Research Research funded by Cancer League of Colorado (193527-ZW) | Colorado Clinical & Translational Sciences Institute (CO-J-20-006) | NIH NCI (R00CA194318-03) | NIH NCI (R00CA193734) | NIH NCI (U01CA231978) | Department of Defense (OC130212) | Department of Defense (OC170228) | MD Anderson Cancer Center (# 5 P30 CA016672-40) | University of Colorado Cancer Center (P30CA046934) |
Tackling the Diversity of Triple-Negative Breast Cancer JOURNAL ARTICLE published 1 December 2013 in Clinical Cancer Research |
HER-2 as a Target for Breast Cancer Therapy JOURNAL ARTICLE published 15 March 2009 in Clinical Cancer Research |
DNA Repair Pathway Profiling and Microsatellite Instability in Colorectal Cancer JOURNAL ARTICLE published 1 September 2006 in Clinical Cancer Research |
Response to Combined Molecular Targeting: Defining the Role of P-STAT3 JOURNAL ARTICLE published 1 February 2011 in Clinical Cancer Research |
The Progression from MGUS to Smoldering Myeloma and Eventually to Multiple Myeloma Involves a Clonal Expansion of Genetically Abnormal Plasma Cells JOURNAL ARTICLE published 1 April 2011 in Clinical Cancer Research |
Mutation of SDHB is a Cause of Hypoxia-Related High-Altitude Paraganglioma JOURNAL ARTICLE published 15 August 2010 in Clinical Cancer Research |
Distribution Patterns of Dendritic Cells and T Cells in Diffuse Large B-Cell Lymphomas Correlate with Prognoses JOURNAL ARTICLE published 15 November 2007 in Clinical Cancer Research |
Multiplexed Evaluation of Microdosed Antineoplastic Agents In Situ in the Tumor Microenvironment of Patients with Soft Tissue Sarcoma JOURNAL ARTICLE published 1 August 2020 in Clinical Cancer Research Research funded by ClinicalTrials.gov (NCT03056599) |
Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis JOURNAL ARTICLE published 15 May 2023 in Clinical Cancer Research |
Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer JOURNAL ARTICLE published 1 February 2018 in Clinical Cancer Research Research funded by Dutch Cancer Society (2014-6696) |
A Phase I Trial of CT900, a Novel α-Folate Receptor–Mediated Thymidylate Synthase Inhibitor, in Patients with Solid Tumors with Expansion Cohorts in Patients with High-Grade Serous Ovarian Cancer JOURNAL ARTICLE published 1 November 2022 in Clinical Cancer Research |
Monitoring Drug-Induced γH2AX as a Pharmacodynamic Biomarker in Individual Circulating Tumor Cells JOURNAL ARTICLE published 1 February 2010 in Clinical Cancer Research |
Abstract 10: Concordance of BAP1, PBRM1, Ki-67, and TOPOIIa protein expression in primary clear cell renal cell carcinoma tumors and patient-matched metastatic tumors JOURNAL ARTICLE published 1 January 2016 in Clinical Cancer Research |
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer JOURNAL ARTICLE published 1 September 2023 in Clinical Cancer Research Research funded by Fondazione AIRC 5 per mille (22759) | University of Padua (DOR funding) | University of Padua (DOR funding) | University of Padua (DOR funding) |
Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients JOURNAL ARTICLE published 15 December 2004 in Clinical Cancer Research |
Anti-Folate Receptor Alpha–Directed Antibody Therapies Restrict the Growth of Triple-negative Breast Cancer JOURNAL ARTICLE published 15 October 2018 in Clinical Cancer Research Research funded by Breakthrough Breast Cancer (147) | Cancer Research UK (CRUK) (C30122/A11527) | Cancer Research UK (CRUK) (C30122/A15774) | Medical Research Council (MRC) (MR/L023091/1) | DH | National Institute for Health Research (NIHR) (IS-BRC-1215-20006) | Cancer Research UK (CRUK) (C10355/A15587) | Academy of Medical Sciences (Josephs) |
Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia JOURNAL ARTICLE published 1 December 2007 in Clinical Cancer Research |
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer JOURNAL ARTICLE published 15 October 2020 in Clinical Cancer Research Research funded by HHS | NIH | National Cancer Institute (3P30 CA0062927) |